Treating insomnia, and reducing suicidal ideation
Start Date 2012-09-01
End Date 2016-08-01
Eligibility Requirements
Eligibility
Gender
Gender
Male
Female
Other
Age Range
Age Range
18 - 25 years
26 - 30 years
31 - 45 years
56 and more years
Vetaran Status
Vetaran Status
Served
Active
Never Served
Service Range
Service Range
0 - 15 years
16 - 20 years
21 and more years
Deployment Status
Deployment Status
Never
Atleast once
Within 2 years
Military Affiliation
Military Affiliation
Army
Navy
Airforce
Marine
Coast Guard
National Guard
Reserves
Short Description
The purpose of this study is to evaluate the effect of treating insomnia with hypnotic (sleep) medication on the severity of suicidal thoughts in depressed outpatients. It is our hope that treatment with a serotonin reuptake inhibitor (SSRI) which is an anti-depressant medication, in addition to a sleep medication called Zolpidem Extended Release (CR) will reduce suicidal thoughts in people with depression and insomnia.
Location Info
Conducted in
Augusta , Georgia
Privacy of the Participants
Does this study require the individual's medical records? - No
Does the sponsor require the name of study participants to be provided? - No
Is this study required to provide individual results to the sponsor? - No
Is this study anonymous in the sense that patient identity is completely anonymized? - Yes
Contact Details
Vaughn,McCall 7067211011 [email protected]
Research Topics
Sleep/Insomnia
More Info
Has this study and the posting of this study on AllyResearch.org been IRB approved - Yes
Are healthy subjects accepted? - No
Does this study utilize any drug treatments? - Yes
Are there financial incentives to participate? - Yes
Financial Incentive for this study : $300
Official title: Reducing Suicidal Ideation Through Insomnia Treatment
University IRB
00000688
Study ID #
00000688
Lead Researcher
Vaughn , McCall
Sponsored By
National Institute of Mental Health